NewAmsterdam Pharma CAO Louise Kooij to depart Aug 31, 2026; severance terms set

NewAmsterdam Pharma Co N.V.

Louise Kooij to step down as Chief Accounting Officer effective August 31, 2026.
Separation agreement includes 12 months base salary lump sum and pro-rated 2026 bonus.
Vesting of outstanding stock options and RSUs extended to Jan 10, 2027; exercise period to Feb 10, 2027.
Agreement includes confidentiality, non-compete, non-disparagement covenants and claims release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.